If the mother-to-be has normal liver function, she can continue her pregnancy, but she must monitor her liver function regularly, once every one to two months on average, and deal with any abnormalities in a timely manner, either by liver-protective treatment or early termination of pregnancy. In addition to regular monitoring of liver function, symptoms such as not wanting to eat, weakness, bloating, itchy skin or jaundice in the mother-to-be are also a warning of possible liver function impairment and should be reviewed at any time at the hospital. If the liver function abnormality is mild, you can use some liver-protective drugs that have no effect on the fetus under the guidance of your doctor, but never skip the medication. Otherwise, if the transaminases remain at a high level, it will not only affect the growth and development of the fetus in the womb and may lead to miscarriage, but also cause liver failure of the mother-to-be, which may even be life-threatening. In the later stages of pregnancy, as the fetus grows and hormone levels change in the body, it will further increase the burden on the mother-to-be’s liver. Remind the mother-to-be not to stay up late, to take more rest, to have a complete nutrition, not to blindly take supplements, to exercise gently, to keep the bowels open and to relax, all of which are beneficial to the mother-to-be’s health and the normal development of the fetus. The actual fact is that you will be able to get a lot more than just a few of the most popular and most popular items. In this regard, experts disagree, because stopping the medication without permission not only fails to provide lasting inhibition of the hepatitis B virus, but may also accelerate the occurrence of drug resistance, lead to the rebound of hepatitis B virus replication, aggravate the disease, and in some cases even lead to hepatitis B outbreaks, liver failure and life-threatening. Sign the consent form with the patient, change the antiviral treatment to lamivudine or tebivudine with higher pregnancy safety class B drugs to continue antiviral treatment and pregnancy, and closely observe the changes in the condition, such as the emergence of fatty liver in pregnancy, the pregnancy must be terminated immediately, such as with the increase of the fetus, the mother-to-be’s liver burden slightly increased, good viral suppression, mild abnormalities of liver function, you can use some of the fetus under the guidance of the doctor Liver-protective drugs that have no effect on the fetus. Some scholars believe that women who are planning to get pregnant can sign a consent form with their patients starting from the 7th month of conception, and use the antiviral drugs lamivudine or telbivudine, which have a higher safety level in pregnancy, and administer hepatitis B vaccine and hepatitis B immunoglobulin at different sites at the same time after the birth of the newborn to reduce the rate of hepatitis B infection in the fetus. The earlier the newborn is given hepatitis B immunoglobulin and hepatitis B vaccine, the better. When it comes to pregnancy and childbirth, hepatitis B mothers are most concerned about mother-to-child interruption, fearing that they will spread their hepatitis B virus to their babies. In the past, some hepatitis B experts recommended that mothers-to-be receive a monthly injection of highly effective hepatitis B immunoglobulin in the 7th, 8th and 9th trimesters of pregnancy to block mother-to-child transmission of the hepatitis B virus. Now the experts think that this dose is too insignificant! How exactly should a mother-to-be block the mother-to-child transmission of hepatitis B? The key is to get the combined hepatitis B vaccine and hepatitis B immune globulin immunization as early as possible within 24 hours of the child’s birth; the earlier the blockade, the better the results, with a success rate of up to 95 percent. In fact, the chance of most mother-to-child transmission originating from in utero infection is very low, and the vast majority of infections occur during labor and delivery. When the fetus is delivered through the birth canal, it may inhale the hepatitis B virus in the mother’s blood, amniotic fluid and other secretions, which is the main route of mother-to-child transmission. However, the good thing is that it takes some time for the hepatitis B virus carried by newborns to fall from the blood circulation to the liver, and as long as hepatitis B immunoglobulin is injected into their bodies in time, it can produce a neutralizing effect in time to remove these viruses and prevent the virus from invading the liver. In order to inject hepatitis B immunoglobulin and hepatitis B vaccine earlier in the first moments of the newborn’s life, the mother-to-be must inform her obstetrician of the need in advance. In addition, a second and third dose of hepatitis B vaccine should be given at 1 month and 6 months after the first vaccination, respectively. Many hepatitis B mothers are concerned about whether they can breastfeed or not. If the mother-to-be is not triple positive or positive for hepatitis B DNA, she can breastfeed.